Mostrar el registro sencillo del ítem

dc.contributor.authorCruz Gómez, Álvaro Javier 
dc.contributor.authorForero, Lucía
dc.contributor.authorLozano Soto, Elena María 
dc.contributor.authorCano-Cano, Fátima
dc.contributor.authorSanmartino, Florencia Soledad 
dc.contributor.authorRashid Abdu Rahim López, Raúl 
dc.contributor.authorPaz Expósito, José 
dc.contributor.authorGómez Ramírez, Jaime D.
dc.contributor.authorEspinosa Rosso, Raúl
dc.contributor.authorGonzález Rosa, Javier Jesús 
dc.contributor.otherMaterno-Infantil y Radiologíaes_ES
dc.contributor.otherPsicologíaes_ES
dc.date.accessioned2022-01-12T10:34:43Z
dc.date.available2022-01-12T10:34:43Z
dc.date.issued2021-11
dc.identifier.issn2332-7812
dc.identifier.urihttp://hdl.handle.net/10498/25960
dc.description.abstractBackground and Objectives To determine the relative importance of global or regional MRI and blood markers of neurodegeneration and neuroaxonal injury in predicting cognitive performance for recently diagnosed patients with multiple sclerosis (MS). Methods Thirty-five newly diagnosed patients with relapsing-remitting MS (RRMS) and 23 healthy controls (HCs) simultaneously completed a full clinical and neuropsychological assessment, structural brain MRI, and serum neurofilament light chain (sNfL) level test. Linear regression analyses were performed to determine which global or regional measures of gray matter (GM) atrophy and cortical thickness (CT), in combination with sNfL levels and clinical scores, are most strongly related to neuropsychological impairment. Results Compared with HCs, patients with MS showed bilateral thalamic GM atrophy (left, p = 0.033; right, p = 0.047) and diminished CT, particularly in the right superior and transverse temporal gyri (p = 0.045; p = 0.037). Regional atrophy failed to add predictive variance, whereas anxiety symptoms, sNfL, and global CT were the best predictors (R-2 = 0.404; p < 0.001) of cognitive outcomes, with temporal thickness accounting for greater variance in cognitive deficits than global CT. Discussion Thalamic GM atrophy and thinning in temporal regions represent a distinctive MRI trait in the early stages of MS. Although sNfL levels alone do not clearly differentiate HCs and patients with RRMS, in combination with global and regional CT, sNfL levels can better explain the presence of underlying cognitive deficits. Hence, cortical thinning and sNfL increases can be considered 2 parallel neurodegenerative markers in the pathogenesis of progression in newly diagnosed patients with MS.es_ES
dc.description.sponsorshipThis work was supported by the European Regional Development Fund and the Spanish Ministry of Science, Innovation and Universities (grant: RTI2018-096951-A-I00) and the Ministry of Economy and Competitiveness (grant: RYC-2015-18467).es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherLIPPINCOTT WILLIAMS & WILKINSes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceNeurol Neuroimmunol Neuroinflamm Nov 2021, 8 (6) e1074es_ES
dc.titleCortical Thickness and Serum NfL Explain Cognitive Dysfunction in Newly Diagnosed Patients With Multiple Sclerosises_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1212/NXI.0000000000001074
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-096951-A-I00/ES/IDENTIFICACION DE UN INDICE DE NEURODEGENERACION TEMPRANA CON VALOR PRONOSTICO EN PACIENTES CON ESCLEROSIS MULTIPLE DE RECIENTE DIAGNOSTICO/es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO//RYC-2015-18467/ES/RYC-2015-18467/es_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Esta obra está bajo una Licencia Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Internacional